The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Open accessAbstract
Immunotherapy may provide valid alternative therapy for patients with hormone-refractory metastatic prostate cancer. However, if the tumor environment exerts a suppressive action on antigen-specific tumor-infiltrating lymphocytes (TIL), immunotherapy will achieve little, if any, success. In this study, we analyzed the modulation of TIL responses by the tumor environment using collagen gel matrix–supported organ cultures of human prostate carcinomas. Our results indicate that human prostatic adenocarcinomas are infiltrated by terminally differentiated cytotoxic T lymphocytes that are, however, in an unresponsive status. We demonstrate the presence of high levels of nitrotyrosines in prostatic TIL, suggesting a local production of peroxynitrites. By inhibiting the activity of arginase and nitric oxide synthase, key enzymes of L-arginine metabolism that are highly expressed in malignant but not in normal prostates, reduced tyrosine nitration and restoration of TIL responsiveness to tumor were achieved. The metabolic control exerted by the tumor on TIL function was confirmed in a transgenic mouse prostate model, which exhibits similarities with human prostate cancer. These results identify a novel and dominant mechanism by which cancers induce immunosuppression in situ and suggest novel strategies for tumor immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Rodriguez, P. C., Quiceno, D. G., Zabaleta, J., Ortiz, B., Zea, A. H., Piazuelo, M. B., Delgado, A., Correa, P., Brayer, J., Sotomayor, E. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0465 · Cited by 1,276
Marincola, F. M., Jaffee, E. M., Hicklin, D. J., & Ferrone, S. (1999) · Advances in Immunology · doi:10.1016/s0065-2776(08)60911-6 · Cited by 1,174
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
The role of nitric oxide in cancer
XU, W., LIU, L. Z., LOIZIDOU, M., AHMED, M., & CHARLES, I. G. (2002) · Cell Research · doi:10.1038/sj.cr.7290133 · Cited by 826
The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal
Lieberman, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1083 · Cited by 789
Roles of nitric oxide in tumor growth.
Jenkins, D. C., Charles, I. G., Thomsen, L. L., Moss, D. W., Holmes, L. S., Baylis, S. A., Rhodes, P., Westmore, K., Emson, P. C., & Moncada, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4392 · Cited by 780
Gorelik, L., & Flavell, R. A. (2001) · Nature Medicine · doi:10.1038/nm1001-1118 · Cited by 770
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages
Xia, Y., & Zweier, J. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6954 · Cited by 691
Inflammation and necrosis promote tumour growth
Vakkila, J., & Lotze, M. T. (2004) · Nature Reviews Immunology · doi:10.1038/nri1415 · Cited by 690
Adoptive-cell-transfer therapy for the treatment of patients with cancer
Dudley, M. E., & Rosenberg, S. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1167 · Cited by 660
Cancer vaccines: between the idea and the reality
Finn, O. J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1150 · Cited by 636
L-arginine metabolism in myeloid cells controls T-lymphocyte functions
Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., & Zanovello, P. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00132-7 · Cited by 592
Self-citationIL-4-Induced Arginase 1 Suppresses Alloreactive T Cells in Tumor-Bearing Mice
Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M., Staib, C., Lowel, M., Sutter, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.270 · Cited by 513
Self-citationBiological selectivity and functional aspects of protein tyrosine nitration
Ischiropoulos, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00814-3 · Cited by 500
Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model
Kaplan‐Lefko, P. J., Chen, T., Ittmann, M. M., Barrios, R. J., Ayala, G. E., Huss, W. J., Maddison, L. A., Foster, B. A., & Greenberg, N. M. (2003) · The Prostate · doi:10.1002/pros.10215 · Cited by 438
Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?
Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F. M., & Anichini, A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.805 · Cited by 401
Inducible Nitric-oxide Synthase Generates Superoxide from the Reductase Domain
Xia, Y., Roman, L. J., Masters, B. S. S., & Zweier, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22635 · Cited by 388
Tian, Q., Streuli, M., Saito, H., Schlossman, S. F., & Anderson, P. (1991) · Cell · doi:10.1016/0092-8674(91)90536-8 · Cited by 382
Tumor‐specific shared antigenic peptides recognized by human T cells
Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E. S., Chapiro, J., Van den Eynde, B. J., Brasseur, F., & Boon, T. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18806.x · Cited by 378
NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?
Schopfer, F. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.006 · Cited by 368
Zippelius, A., Batard, P., Rubio-Godoy, V., Bioley, G., Liénard, D., Lejeune, F., Rimoldi, D., Guillaume, P., Meidenbauer, N., Mackensen, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3066 · Cited by 361
Proteomic method identifies proteins nitrated in vivo during inflammatory challenge
Aulak, K. S., Miyagi, M., Yan, L., West, K. A., Massillon, D., Crabb, J. W., & Stuehr, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221269198 · Cited by 350
TCR ζ-chain downregulation: curtailing an excessive inflammatory immune response
Baniyash, M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1434 · Cited by 344
Blocking NO synthesis: how, where and why?
Vallance, P., & Leiper, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd960 · Cited by 331
Brito, C., Naviliat, M., Tiscornia, A. C., Vuillier, F., Gualco, G., Dighiero, G., Radi, R., & Cayota, A. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3356 · Cited by 306
Peroxynitrite rapidly permeates phospholipid membranes
Marla, S. S., Lee, J., & Groves, J. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14243 · Cited by 306
Chang, C., Liao, J. C., & Kuo, L. (2001) · PubMed · Cited by 294
Wang, E., Miller, L. D., Ohnmacht, G. A., D, S. M. M., Pérez‐Díez, A., Petersen, D. W., Zhao, Y., Simon, R., Powell, J. I., Asaki, E., et al. (2002) · PubMed · Cited by 260
Vesalainen, S., Lipponen, P., Talja, M., & Syrjänen, K. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)e0159-2 · Cited by 254
Arginases I and II: do their functions overlap?
Cederbaum, S. D., Yu, H., Grody, W. W., Kern, R. M., Yoo, P., & Iyer, R. K. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.10.012 · Cited by 236
Intratumoral CD8+ T Lymphocytes as a Prognostic Factor of Survival in Endometrial Carcinoma
Kondratiev, S., Sabo, E., Yakirevich, E., Lavie, O., & Resnick, M. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0732-3 · Cited by 224
Peroxynitrite: reactive, invasive and enigmatic
Groves, J. T. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80036-2 · Cited by 206
Trambas, C. M., & Griffiths, G. M. (2003) · Nature Immunology · doi:10.1038/ni0503-399 · Cited by 191
Dynamics of protein nitration in cells and mitochondria
Aulak, K. S., Koeck, T., Crabb, J. W., & Stuehr, D. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00743.2003 · Cited by 186
Rapid and Selective Oxygen-regulated Protein Tyrosine Denitration and Nitration in Mitochondria
Koeck, T., Fu, X., Hazen, S. L., Crabb, J. W., Stuehr, D. J., & Aulak, K. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401586200 · Cited by 173
Signaling defects in T lymphocytes of patients with malignancy
Whiteside, T. L. (1999) · Cancer Immunology, Immunotherapy · doi:10.1007/s002620050585 · Cited by 162
Radoja, S., Saio, M., Schaer, D., Koneru, M., Vukmanovic, S., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5042 · Cited by 160
Xu, W., Liu, L., Smith, G. C. M., & Charles, L. G. (2000) · Nature Cell Biology · doi:10.1038/35014028 · Cited by 127
Antigen receptor-regulated exocytosis in cytotoxic T lymphocytes.
Takayama, H., & Sitkovsky, M. V. (1987) · The Journal of Experimental Medicine · doi:10.1084/jem.166.3.725 · Cited by 126
Classical and Slow-Binding Inhibitors of Human Type II Arginase
Colleluori, D. M., & Ash, D. E. (2001) · Biochemistry · doi:10.1021/bi010783g · Cited by 111
Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.
Aaltoma, S. H., Lipponen, P., & Kosma, V. M. (2001) · PubMed · Cited by 103
T-cell responses of vaccinated cancer patients
Coulie, P. G., & van der Bruggen, P. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00009-8 · Cited by 89
In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation
Moulian, N., Truffault, F., Gaudry-Talarmain, Y. M., Serraf, A. E., & Berrih‐Aknin, S. (2001) · Blood · doi:10.1182/blood.v97.11.3521 · Cited by 86
Radoja, S., & Frey, A. B. (2000) · Molecular Medicine · doi:10.1007/bf03401788 · Cited by 78
Denitration of peroxynitrite-treated proteins by ‘protein nitratases’ from rat brain and heart
Kuo, W., Kanadia, R., Shanbhag, V. P., & Toro, R. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007024126947 · Cited by 68
Immune Cells in the Tumor Microenvironment
Whiteside, T. L. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-5357-1_27 · Cited by 68
Whiteside, T. L. (1998) · PubMed · Cited by 65
Radoja, S., Saio, M., & Frey, A. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6074 · Cited by 59
Cellular immunotherapy for cancer
Armstrong, A. C., Eaton, D., & Ewing, J. C. (2001) · BMJ · doi:10.1136/bmj.323.7324.1289 · Cited by 56
Wang, J., Torbenson, M. S., Wang, Q. I., Ro, J. Y., & Becich, M. J. (2003) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(02)00208-9 · Cited by 51
Possible implications of arginase and diamine oxidase in prostatic carcinoma.
Keskinege, A., Elgün, S., & Yilmaz, E. (2001) · PubMed · Cited by 48
Arginase Activity is Inhibited by l -NAME, both In Vitro and In Vivo
Reisser, D., Onier, N., & Jeannin, J. (2002) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/1475636021000006252 · Cited by 39
Characteristics of nonmalignant and malignant human prostate in organ culture.
Varani, J., Dame, M. K., Wojno, K. J., Schuger, L. A., & Johnson, K. J. (1999) · PubMed · Cited by 23
Hsing (1996) · doi:10.1002/(sici)1097-0215(19960208)65:4 · Cited by 1
Cited by
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
The metabolic signature of macrophage responses
Viola, A., Munari, F., Sánchez-Rodríguez, R., Scolaro, T., & Castegna, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01462 · Cited by 2,021
Self-citationMyeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Self-citationSubsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Metadata
- Authors
- Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., & Viola, A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-04-11
- Volume
- 201
- Issue
- 8
- Pages
- 1257-1268
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2154339682
- Cited by
- 396
- References
- 61
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.